Tolperisone

Tolperisone
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Tolperisone is a centrally acting muscle relaxant used in the treatment of increased muscle tone and muscle spasms associated with various neurological conditions. It is particularly effective in conditions such as multiple sclerosis, spinal cord injury, and cerebral palsy.

Pharmacology

Tolperisone acts primarily by blocking voltage-gated sodium and calcium channels in the central nervous system, which leads to a reduction in muscle tone and spasticity. Unlike other muscle relaxants, Tolperisone does not cause sedation, making it a preferred choice for patients who need to maintain alertness.

Indications

Tolperisone is indicated for the treatment of:

• Muscle spasms associated with neurological disorders
• Spasticity following stroke
• Muscle stiffness in cerebral palsy
• Spinal cord injuries

Dosage and Administration

Tolperisone is typically administered orally in tablet form. The usual adult dose ranges from 150 mg to 450 mg per day, divided into three doses. The dosage may be adjusted based on the patient's response and the severity of symptoms.

Side Effects

Common side effects of Tolperisone include:

• Nausea
• Vomiting
• Headache
• Dizziness
• Hypotension

Rarely, patients may experience allergic reactions, including skin rash and itching. It is important to monitor patients for any adverse effects and adjust the dosage accordingly.

Contraindications

Tolperisone is contraindicated in patients with:

• Known hypersensitivity to Tolperisone or any of its components
• Myasthenia gravis
• Severe liver or kidney impairment

Drug Interactions

Tolperisone may interact with other central nervous system depressants, enhancing their effects. Caution is advised when co-administering with drugs such as benzodiazepines or opioids.

Mechanism of Action

Tolperisone's mechanism of action involves the inhibition of voltage-gated sodium and calcium channels, which reduces the excitability of neurons in the central nervous system. This leads to a decrease in muscle tone and spasticity without affecting consciousness or alertness.

Research and Development

Ongoing research is exploring the potential of Tolperisone in treating other conditions characterized by muscle spasticity and pain. Studies are also investigating its long-term safety and efficacy in various patient populations.

Also see

• Muscle relaxant
• Spasticity
• Multiple sclerosis
• Cerebral palsy

Tolperisone

• 
  Tolperisone 2D Skeletal
• 
  Tolperisone 3D

Tolperisone

• 
  Tolperisone 2D Skeletal
• 
  Tolperisone 3D